These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

100 related items for PubMed ID: 9808686

  • 1. Anandamide, an endogenous cannabinoid, has a very low physical dependence potential.
    Aceto MD, Scates SM, Razdan RK, Martin BR.
    J Pharmacol Exp Ther; 1998 Nov; 287(2):598-605. PubMed ID: 9808686
    [Abstract] [Full Text] [Related]

  • 2. Effects of SR 141716A after acute or chronic cannabinoid administration in dogs.
    Lichtman AH, Wiley JL, LaVecchia KL, Neviaser ST, Arthur DB, Wilson DM, Martin BR.
    Eur J Pharmacol; 1998 Sep 18; 357(2-3):139-48. PubMed ID: 9797029
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. (R)-methanandamide and Delta 9-THC as discriminative stimuli in rats: tests with the cannabinoid antagonist SR-141716 and the endogenous ligand anandamide.
    Järbe TU, Lamb RJ, Lin S, Makriyannis A.
    Psychopharmacology (Berl); 2001 Aug 18; 156(4):369-80. PubMed ID: 11498713
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. (R)-Methanandamide and delta9-tetrahydrocannabinol-induced operant rate decreases in rats are not readily antagonized by SR-141716A.
    Järbe TU, Lamb RJ, Liu Q, Makriyannis A.
    Eur J Pharmacol; 2003 Apr 11; 466(1-2):121-7. PubMed ID: 12679148
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Differential blockade of the antinociceptive effects of centrally administered cannabinoids by SR141716A.
    Welch SP, Huffman JW, Lowe J.
    J Pharmacol Exp Ther; 1998 Sep 11; 286(3):1301-8. PubMed ID: 9732392
    [Abstract] [Full Text] [Related]

  • 14. A comparison of EDHF-mediated and anandamide-induced relaxations in the rat isolated mesenteric artery.
    White R, Hiley CR.
    Br J Pharmacol; 1997 Dec 11; 122(8):1573-84. PubMed ID: 9422801
    [Abstract] [Full Text] [Related]

  • 15. Cannabinoid precipitated withdrawal by the selective cannabinoid receptor antagonist, SR 141716A.
    Aceto MD, Scates SM, Lowe JA, Martin BR.
    Eur J Pharmacol; 1995 Aug 25; 282(1-3):R1-2. PubMed ID: 7498260
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Anandamide induces overeating: mediation by central cannabinoid (CB1) receptors.
    Williams CM, Kirkham TC.
    Psychopharmacology (Berl); 1999 Apr 25; 143(3):315-7. PubMed ID: 10353436
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Characterization of delta9-tetrahydrocannabinol and anandamide antinociception in nonarthritic and arthritic rats.
    Smith FL, Fujimori K, Lowe J, Welch SP.
    Pharmacol Biochem Behav; 1998 May 25; 60(1):183-91. PubMed ID: 9610941
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.